Genetics - Predisposition To Cancer Flashcards
1
Q
Germline mutations
A
- inherited from single alteration in egg or sperm
- are heritable
- cause cancer family syndromes
2
Q
Somatic mutations
A
- occur in non germ line tissues
- are nonheritable
3
Q
BRCA1 and 2 Associated Cancers: Lifetime Risk
A
- Breast cancer 60%-80% (often early age at onset)
- Second primary breast cancer 40%-60%
- Ovarian cancer 20%-50%
- Males: increased risk of prostate cancer and breast cancer esp. BRCA2
4
Q
When to Suspect
Hereditary Cancer Syndrome
A
- Cancer in 2 or more close relatives (on same side of family)
- Early age at diagnosis
- Multiple primary tumors
- Bilateral or multiple rare cancers
- Characteristic pattern of tumours (e.g. breast and ovary)
- Evidence of autosomal dominant transmission
5
Q
Clinical Genetics Consultation
A
- Go through family history
- Risk estimation
- Explanation of basis of risk
- Interventions
- increased awareness of symptoms / signs
- lifestyle - diet, smoking, exercise,
- Prevention – oestrogen, aspirin use
- screening
- prophylactic surgery - Genetic testing - consider in high risk
6
Q
Breast Cancer Surveillance Options
A
- Breast awareness
- Early clinical surveillance 5 yr
7
Q
BRCA1/2 Gene Carriers:
Prophylactic Mastectomy
A
- Removes most but not all breast tissue
- Significantly reduces breast cancer risk in women with a family history
- Total (simple) mastectomy removes more breast tissue than subcutaneous mastectomy
- BRCA1 mutation-positive women breast cancer incidence reduced to 5%
8
Q
Prophylactic Oophorectomy
A
-Eliminates risk of primary ovarian cancer;
however, peritoneal carcinomatosis may
still occur
-Laparoscopic oophorectomy reduces postsurgical morbidity
-Induces surgical menopause but HRT till 50 does not change BRCA risk
-Risk of subsequent BRCA halved in mutation-positive women
9
Q
Benefits of Genetic Testing
A
- identifies highest risk
- identifies non-carriers in families with a known mutation
- allows early detection and prevention strategies
10
Q
Risks, and Limitations of Genetic Testing
A
- does not detect all mutations
- continued risk of sporadic cancer
- efficacy of interventions is variable
- may result in psychological or economic harm